|
Delayed
Hong Kong S.E.
07:54:10 17/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.270 HKD | +1.79% |
|
-2.16% | -50.00% |
Company Valuation: Cutia Therapeutics
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3,030 | 2,120 | 1,482 | 696.4 | - | - |
| Change | - | -30.05% | -30.06% | -53.02% | - | - |
| Enterprise Value (EV) 1 | 2,471 | 2,055 | 1,469 | 765.1 | 696.4 | 534.7 |
| Change | - | -16.83% | -28.53% | -47.9% | -8.98% | -23.22% |
| P/E | -1.04x | -4.72x | -3.96x | -4.18x | 14.7x | 1.85x |
| PBR | 2.25x | 2.17x | 1.52x | 1.51x | 1.37x | 1x |
| PEG | -0x | 0.1x | 0.1x | 0.1x | -0x | 0x |
| Capitalization / Revenue | 22x | 7.58x | 4.41x | 1.08x | 0.59x | 0.4x |
| EV / Revenue | 18x | 7.35x | 4.37x | 1.18x | 0.59x | 0.31x |
| EV / EBITDA | -4.96x | -4.89x | -5.69x | -6.44x | 8.54x | 1.2x |
| EV / EBIT | -4.58x | -4.46x | -4.89x | -5.34x | 13.2x | 2.19x |
| EV / FCF | -5.65x | -4.38x | -4.87x | -2.49x | -24.6x | 8.67x |
| FCF Yield | -17.7% | -22.8% | -20.5% | -40.1% | -4.06% | 11.5% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -9.6 | -1.41 | -1.03 | -0.4581 | 0.1304 | 1.038 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 137.6 | 279.6 | 336.2 | 645.9 | 1,180 | 1,738 |
| EBITDA 1 | -498 | -419.9 | -257.9 | -118.8 | 81.56 | 444.6 |
| EBIT 1 | -538.9 | -461.1 | -300.1 | -143.3 | 52.79 | 244.1 |
| Net income 1 | -1,964 | -433.8 | -340.2 | -145.7 | 44.25 | 330.6 |
| Net Debt 1 | -559.6 | -64.73 | -13.8 | 68.7 | - | -161.7 |
| Reference price 2 | 9.967 | 6.653 | 4.080 | 1.917 | 1.917 | 1.917 |
| Nbr of stocks (in thousands) | 304,024 | 318,588 | 363,368 | 363,368 | - | - |
| Announcement Date | 27/03/24 | 24/03/25 | 24/03/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.18x | 1.18x | -6.44x | - | 103M | |
| 33.76x | 12.18x | 24.85x | 0.59% | 1,052B | |
| 28.96x | - | - | 2.06% | 627B | |
| 31.84x | 7.42x | 15.42x | 2.75% | 441B | |
| 19.79x | 4.7x | 11.65x | 2.81% | 349B | |
| 21.42x | 5.54x | 13.77x | 2.89% | 287B | |
| 19.89x | 4.11x | 11.68x | 2.14% | 241B | |
| 26.26x | 6.84x | 12.14x | 2.43% | 224B | |
| 13.32x | 4.79x | 9.96x | 3.83% | 202B | |
| -42.28x | 6.13x | 23.96x | 2.38% | 172B | |
| Average | 14.88x | 5.88x | 13.00x | 2.43% | 359.53B | |
| Weighted average by Cap. | 24.17x | 8.04x | 17.73x | 2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2487 Stock
- Valuation Cutia Therapeutics
Select your edition
All financial news and data tailored to specific country editions
